Examining the role of nasopharyngeal-associated lymphoreticular tissue (NALT) in mouse responses to vaccines

Journal of Visualized Experiments

Volumn , Issue 66, 2012, Pages

  Cisney, Emily D ^a   Fernandez, Stefan ^a   Hall, Shannan I ^a   Krietz, Gale A ^a   Ulrich, Robert G ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Antibody; Immunology; Infectious diseases; Issue 66; Mouse; Mucosal immunity; NALT ablation; NALT culture; NALT deficient mice; Nasal vaccination; Nasopharyngeal associated lymphoreticular tissue

Indexed keywords

VACCINE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; FEMALE; IMMUNOLOGY; LYMPHOID TISSUE; MOUSE; NASOPHARYNX;

ANIMALS; FEMALE; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; NASOPHARYNX; VACCINES;

EID: 84868288748     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3960     Document Type: Article

References (14)

1. Wiley, J.A., Tighe, M.P., & Harmsen, A.G. Upper respiratory tract resistance to influenza infection is not prevented by the absence of either nasal-associated lymphoid tissue or cervical lymph nodes. J. Immunol. 175, 3186-3196 (2005).
2. Zuercher A.W., et al. Intranasal immunisation with conjugate vaccine protects mice from systemic and respiratory tract infection with Pseudomonas aeruginosa. Vaccine. 24, 4333-4342 (2006).
3. Fernandez, S., Cisney, E.D., Hall, S.I., & Ulrich, R.G. Nasal immunity to staphylococcal toxic shock is controlled by the nasopharynxassociated lymphoid tissue. Clin. Vaccine Immunol. 18, 667-675 (2011).
4. Asanuma, H., et al. Isolation and characterization of mouse nasal-associated lymphoid tissue. J. Immunol. Methods. 202, 123-131 (1997).
5. Casteleyn, C., Broos, A.M., Simoens, P., & Van den Broeck, W. NALT (nasal cavity-associated lymphoid tissue) in the rabbit. Vet. Immunol. Immunopathol. 133, 212-218 (2010).
6. Debertin, A.S., et al. Nasal-associated lymphoid tissue (NALT): frequency and localization in young children. Clin. Exp. Immunol. 134, 503-507 (2003).
7. Csencsits, K.L., Jutila, M.A., & Pascual, D.W. Nasal-associated lymphoid tissue: phenotypic and functional evidence for the primary role of peripheral node addressin in naïve lymphocyte adhesion to high endothelial venules in a mucosal site. J. Immunol. 163, 1382-1389 (1999).
8. Zuercher, A.W., et al. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses. J. Immunol. 168, 1796-1803 (2002).
9. Park, H.S., Francis, K.P., Yu, J., & Cleary, P.P. Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J. Immunol. 171, 2532-2537 (2003).
10. Tyrer P., Foxwell, A.R., Cripps, A.W., Apicella, M.A., & Kyd, J.M. Microbial pattern recognition receptors mediate M-cell uptake of a gramnegative bacterium. Infect. Immun. 74, 625-631 (2006).
11. Wu, A.W. & Russell, M.W. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol. Res. 16, 187-201 (1997).
12. Harmsen, A., et al. Cutting edge: organogenesis of nasal-associated lymphoid tissue (NALT) occurs independently of lymphotoxin-alpha (LT alpha) and retinoic acid receptor-related orphan receptor-gamma, but the organization of NALT is LT alpha dependent. J. Immunol. 168, 986-900 (2002).
13. Rangel-Moreno, J., et al. Role of CXC chemokine ligand 13, CC chemokine ligand (CCL) 19, and CCL21 in the organization and function of nasal-associated lymphoid tissue. J. Immunol. 175, 4904-4913 (2005).
14. Morefield, G.L., Hawkins, L.D., Ishizaka, S.T., Kissner, T.L., & Ulrich, R.G. Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome. Clin. Vaccine Immunol. 14, 1499-1504 (2007).